Omega Fund Management as of Dec. 31, 2024
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bicara Therapeutics Common Stock (BCAX) | 31.8 | $38M | 2.2M | 17.42 | |
| Nuvation Bio Common Stock Class A (NUVB) | 28.8 | $35M | 13M | 2.66 | |
| Replimune Group Common Stock (REPL) | 19.8 | $24M | 2.0M | 12.11 | |
| Lexeo Therapeutics Common Stock (LXEO) | 6.5 | $7.8M | 1.2M | 6.58 | |
| Alumis Common Stock (ALMS) | 4.3 | $5.1M | 653k | 7.86 | |
| Ikena Oncology Common Stock (IKNA) | 3.1 | $3.7M | 2.2M | 1.64 | |
| enGene Holdings Common Stock (ENGN) | 2.9 | $3.5M | 526k | 6.65 | |
| Immunic Common Stock (IMUX) | 1.5 | $1.8M | 1.8M | 1.00 | |
| Sana Biotechnology Common Stock (SANA) | 1.1 | $1.4M | 844k | 1.63 | |
| enGene Holdings Warrant (ENGNW) | 0.2 | $271k | 322k | 0.84 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 0.0 | $58k | 251k | 0.23 |
